$833 Million is the total value of Perceptive Advisors's 118 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 93.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CELG | Sell | CELGENE CORP | $86,034,000 | -23.5% | 509,200 | -30.2% | 10.33% | +123.3% |
ACRX | Sell | ACELRX PHARMACEUTICALS INC | $74,353,000 | -41.1% | 6,574,060 | -43.9% | 8.93% | +71.7% |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $70,981,000 | -68.7% | 3,484,579 | -84.9% | 8.52% | -8.6% |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $60,311,000 | -12.0% | 811,728 | -10.2% | 7.24% | +156.7% |
TSRO | Sell | TESARO INC | $40,851,000 | -65.2% | 1,446,570 | -52.2% | 4.91% | +1.6% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $39,076,000 | -59.6% | 4,183,737 | -51.0% | 4.69% | +17.9% |
AEGR | Sell | AEGERION PHARMACEUTICALS INC | $31,775,000 | -92.0% | 447,785 | -90.4% | 3.82% | -76.8% |
F113PS | Sell | COVIDIEN PLC | $25,526,000 | -0.9% | 374,826 | -11.3% | 3.07% | +189.2% |
EXAS | Sell | EXACT SCIENCES CORP | $23,031,000 | -44.2% | 1,969,903 | -43.7% | 2.77% | +62.8% |
MNKD | Buy | MANNKIND CORP | $19,772,000 | +499.2% | 3,795,000 | +555.4% | 2.38% | +1646.3% |
MGNX | New | MACROGENICS INC | $19,687,000 | – | 717,705 | +100.0% | 2.36% | – |
WAG | Sell | WALGREEN CO | $18,496,000 | -8.5% | 322,000 | -14.3% | 2.22% | +166.9% |
ABBV | New | ABBVIE INC | $18,484,000 | – | 350,000 | +100.0% | 2.22% | – |
DYAX | Sell | DYAX CORP | $17,565,000 | -24.4% | 2,332,674 | -31.1% | 2.11% | +120.7% |
NEPT | Sell | NEPTUNE TECHNOLOGIES BIORESO | $17,111,000 | -50.0% | 5,900,444 | -45.2% | 2.06% | +45.7% |
MYL | Sell | MYLAN INC | $17,035,000 | -51.5% | 392,500 | -57.4% | 2.05% | +41.4% |
XNCR | New | XENCOR INC | $14,338,000 | – | 1,568,672 | +100.0% | 1.72% | – |
INCY | New | INCYTE CORP | $13,609,000 | – | 268,800 | +100.0% | 1.64% | – |
SRPT | New | Sarepta Therapeutics Incput | $13,241,000 | – | 650,000 | +100.0% | 1.59% | – |
BIIB | New | BIOGEN IDEC INC | $11,190,000 | – | 40,000 | +100.0% | 1.34% | – |
CI | Sell | CIGNA CORPORATION | $10,935,000 | -68.1% | 125,000 | -72.0% | 1.31% | -6.9% |
SPNC | Buy | SPECTRANETICS CORP | $8,656,000 | +67.2% | 346,254 | +12.4% | 1.04% | +388.3% |
RLYP | New | RELYPSA INC | $8,530,000 | – | 341,200 | +100.0% | 1.02% | – |
New | ANACOR PHARMACEUTICALS INC | $8,181,000 | – | 487,542 | +100.0% | 0.98% | – | |
HNT | Sell | HEALTH NET INC | $8,094,000 | -71.9% | 272,775 | -69.9% | 0.97% | -17.9% |
HTWR | Buy | HEARTWARE INTL INC | $7,977,000 | +989.8% | 84,900 | +749.0% | 0.96% | +3093.3% |
CHTP | Sell | CHELSEA THERAPEUTICS INTL LT | $7,538,000 | -63.1% | 1,701,639 | -75.1% | 0.90% | +7.6% |
RTRX | New | RETROPHIN INC | $7,368,000 | – | 1,052,692 | +100.0% | 0.88% | – |
CTIC | Sell | CELL THERAPEUTICS INC | $7,133,000 | -68.5% | 3,715,000 | -73.4% | 0.86% | -8.2% |
GENTY | New | GENTIUM S P Asponsored adr | $6,852,000 | – | 120,000 | +100.0% | 0.82% | – |
CVS | Buy | CVS CAREMARK CORPORATION | $6,393,000 | +2340.1% | 89,330 | +1842.0% | 0.77% | +6881.8% |
ZLTQ | Buy | ZELTIQ AESTHETICS INC | $5,779,000 | +2230.2% | 305,593 | +1015.1% | 0.69% | +6840.0% |
ARNI | New | ARNO THERAPEUTICS | $5,697,000 | – | 2,034,721 | +100.0% | 0.68% | – |
TARO | New | TARO PHARMACEUTICAL INDS LTD | $5,598,000 | – | 56,602 | +100.0% | 0.67% | – |
AERI | New | AERIE PHARMACEUTICALS INC | $5,388,000 | – | 300,000 | +100.0% | 0.65% | – |
ECYT | Sell | ENZO BIOCHEM INC | $5,234,000 | -53.1% | 671,300 | -19.8% | 0.63% | +36.7% |
ACST | Buy | ACASTI PHARMA INC | $5,236,000 | +615.3% | 4,389,685 | +1321.7% | 0.63% | +1996.7% |
CSU | Sell | CAPITAL SR LIVING CORP | $5,008,000 | -80.7% | 208,753 | -83.0% | 0.60% | -43.8% |
INFI | Sell | INFINITY PHARMACEUTICALS INC | $4,834,000 | -29.0% | 350,000 | -10.3% | 0.58% | +107.5% |
ATHX | Sell | ATHERSYS INC | $4,252,000 | -39.7% | 1,700,887 | -60.4% | 0.51% | +76.2% |
ALQA | New | ALLIQUA | $4,041,000 | – | 557,491 | +100.0% | 0.48% | – |
GILD | Sell | GILEAD SCIENCES INC | $3,758,000 | -96.5% | 50,000 | -97.1% | 0.45% | -89.9% |
TNDM | New | TANDEM DIABETES CARE INC | $3,236,000 | – | 125,600 | +100.0% | 0.39% | – |
VSTM | Sell | VERASTEM INC | $2,517,000 | -58.1% | 220,000 | -54.4% | 0.30% | +22.3% |
OPHT | New | OPHTHOTECH CORP | $2,426,000 | – | 75,000 | +100.0% | 0.29% | – |
MGCD | Sell | MGC DIAGNOSTICS CORP | $2,274,000 | -40.5% | 179,619 | -48.5% | 0.27% | +73.9% |
CMRX | New | CHIMERIX INC | $2,262,000 | – | 150,000 | +100.0% | 0.27% | – |
RGEN | Buy | REPLIGEN CORPput | $2,251,000 | +48.7% | 165,000 | +20.8% | 0.27% | +335.5% |
ZGNX | New | ZOGENIX INC | $2,236,000 | – | 650,000 | +100.0% | 0.27% | – |
FPRX | New | FIVE PRIME THERAPEUTICS INC | $2,225,000 | – | 132,500 | +100.0% | 0.27% | – |
ECYT | New | ENDOCYTE INCcall | $2,138,000 | – | 200,000 | +100.0% | 0.26% | – |
ECYT | Sell | ENDOCYTE INCput | $2,138,000 | -58.5% | 200,000 | -48.2% | 0.26% | +21.2% |
AUXL | New | AUXILIUM PHARMACEUTICALS INC | $2,074,000 | – | 100,000 | +100.0% | 0.25% | – |
CSBR | Sell | CHAMPION ONCOLOGY | $1,950,000 | -64.2% | 1,625,744 | -47.8% | 0.23% | +4.5% |
ZBH | New | ZIMMER HLDGS INC | $1,864,000 | – | 20,000 | +100.0% | 0.22% | – |
CLVS | Sell | CLOVIS ONCOLOGY INC | $1,843,000 | -92.2% | 30,585 | -92.1% | 0.22% | -77.3% |
IDIX | New | IDENIX PHARMACEUTICALS INCcall | $1,794,000 | – | 300,000 | +100.0% | 0.22% | – |
NBS | Sell | NEOSTEM INC | $1,566,000 | -72.4% | 229,593 | -65.4% | 0.19% | -19.3% |
BCRX | Sell | BIOCRYST PHARMACEUTICALS | $1,501,000 | -45.9% | 197,500 | -48.2% | 0.18% | +57.9% |
SNTS | Sell | SANTARUS INC | $1,451,000 | -94.0% | 45,400 | -95.7% | 0.17% | -82.4% |
SHPG | New | SHIRE PLCsponsored adr | $1,413,000 | – | 10,000 | +100.0% | 0.17% | – |
ANTH | Sell | ANTHERA PHARMACEUTICALS INC | $1,325,000 | -61.8% | 431,456 | -50.0% | 0.16% | +11.2% |
RPRX | Sell | REPROS THERAPEUTICS INC | $1,315,000 | -98.3% | 71,879 | -97.6% | 0.16% | -95.2% |
DXCM | Sell | DEXCOM INC | $1,062,000 | -74.1% | 30,000 | -79.3% | 0.13% | -24.3% |
TBIO | Sell | TRANSGENOMIC INC | $1,004,000 | -40.1% | 2,207,500 | -50.0% | 0.12% | +75.4% |
CRIS | New | CURIS INC | $987,000 | – | 350,000 | +100.0% | 0.12% | – |
VVUS | Sell | VIVUS INCput | $908,000 | -83.1% | 100,000 | -82.7% | 0.11% | -50.9% |
ONTY | Sell | ONCOTHYREON INC | $880,000 | -55.7% | 500,000 | -48.2% | 0.11% | +29.3% |
MDXG | New | MIMEDX GROUP INC | $874,000 | – | 100,000 | +100.0% | 0.10% | – |
UPI | Sell | UROPLASTY INC | $857,000 | -57.4% | 313,989 | -48.4% | 0.10% | +24.1% |
UTHR | New | UNITED THERAPEUTICS CORP DEL | $792,000 | – | 7,000 | +100.0% | 0.10% | – |
New | OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $732,000 | – | 750,000 | +100.0% | 0.09% | – | |
SCAI | New | SURGICAL CARE AFFILIATES INC | $697,000 | – | 20,000 | +100.0% | 0.08% | – |
NSPH | Sell | NANOSPHERE INC | $676,000 | -50.2% | 295,000 | -56.6% | 0.08% | +44.6% |
HOLX | New | HOLOGIC INCcall | $559,000 | – | 25,000 | +100.0% | 0.07% | – |
BLUE | New | BLUEBIRD BIO INC | $420,000 | – | 20,000 | +100.0% | 0.05% | – |
NCT | New | NEWCASTLE INVT CORP | $402,000 | – | 70,000 | +100.0% | 0.05% | – |
MDGN | Sell | MEDGENICS INC | $367,000 | -84.3% | 61,263 | -79.6% | 0.04% | -54.2% |
ATHN | New | ATHENAHEALTH INCcall | $336,000 | – | 2,500 | +100.0% | 0.04% | – |
STEM | Sell | STEMCELLS INC | $334,000 | -57.1% | 271,600 | -41.4% | 0.04% | +25.0% |
XNPT | Sell | XENOPORT INC | $288,000 | -47.4% | 50,000 | -48.2% | 0.04% | +52.2% |
CUTR | Sell | CUTERA INC | $228,000 | +3.6% | 22,400 | -9.7% | 0.03% | +200.0% |
INSYQ | New | INSYS THERAPEUTICS INC NEW | $221,000 | – | 5,722 | +100.0% | 0.03% | – |
ILMN | New | ILLUMINA INC | $221,000 | – | 2,000 | +100.0% | 0.03% | – |
LCI | New | LANNET INC | $223,000 | – | 6,744 | +100.0% | 0.03% | – |
MDSO | New | MEDIDATA SOLUTIONS INC | $220,000 | – | 3,642 | +100.0% | 0.03% | – |
MYGN | New | MYRIAD GENETICS INCput | $210,000 | – | 10,000 | +100.0% | 0.02% | – |
NAVB | Sell | NAVIDEA BIOPHARMACEUTICALS Iput | $207,000 | -66.5% | 100,000 | -57.1% | 0.02% | 0.0% |
TRNX | New | TORNIER N V | $188,000 | – | 10,000 | +100.0% | 0.02% | – |
PTIE | New | PAIN THERAPEUTICS INC | $172,000 | – | 35,506 | +100.0% | 0.02% | – |
DVA | Sell | DAVITA HEALTHCARE PARTNERS I | $151,000 | -42.4% | 2,382 | -48.4% | 0.02% | +63.6% |
ESRX | New | EXPRESS SCRIPTS HLDG CO | $146,000 | – | 2,080 | +100.0% | 0.02% | – |
HRC | New | HILL ROM HLDGS INC | $152,000 | – | 3,687 | +100.0% | 0.02% | – |
New | ANALOGIC CORP | $146,000 | – | 1,644 | +100.0% | 0.02% | – | |
CNC | Sell | CENTENE CORP DEL | $154,000 | -49.0% | 2,610 | -44.6% | 0.02% | +50.0% |
New | ASTRAZENECA PLCsponsored adr | $152,000 | – | 2,558 | +100.0% | 0.02% | – | |
IPXL | New | IMPAX LABORATORIES INC | $150,000 | – | 5,962 | +100.0% | 0.02% | – |
OCR | Sell | OMNICARE INC | $150,000 | -46.4% | 2,492 | -50.7% | 0.02% | +50.0% |
ALR | Sell | ALERE INC | $149,000 | -44.8% | 4,127 | -53.4% | 0.02% | +63.6% |
RAD | New | RITE AID CORP | $76,000 | – | 14,924 | +100.0% | 0.01% | – |
FLDM | New | FLUIDIGM CORP DEL | $78,000 | – | 2,030 | +100.0% | 0.01% | – |
ENDP | New | ENDO HEALTH SOLUTIONS INC | $77,000 | – | 1,138 | +100.0% | 0.01% | – |
PBYI | New | PUMA BIOTECHNOLOGY INC | $76,000 | – | 735 | +100.0% | 0.01% | – |
AFFX | New | AFFYMETRIX INC | $73,000 | – | 8,538 | +100.0% | 0.01% | – |
GERN | New | GERON CORP | $22,000 | – | 4,684 | +100.0% | 0.00% | – |
IMMU | Sell | IMMUNOMEDICS INC | $13,000 | -99.9% | 2,853 | -99.8% | 0.00% | -99.5% |
AXGN | Sell | AXOGEN INC | $20,000 | -50.0% | 4,500 | -50.0% | 0.00% | 0.0% |
CBMXW | Sell | COMBIMATRIX CORPORATION*w exp 05/01/201 | $3,000 | -25.0% | 5,000 | -50.0% | 0.00% | – |
STML | Sell | STEMLINE THERAPEUTICS INC | $1,000 | -100.0% | 38 | -100.0% | 0.00% | -100.0% |
KYTH | Exit | KYTHERA BIOPHARMACEUTICALS I | $0 | – | -5,530 | -100.0% | -0.01% | – |
HNGR | Exit | HANGER INC | $0 | – | -8,160 | -100.0% | -0.01% | – |
AMSG | Exit | AMSURG CORP | $0 | – | -6,830 | -100.0% | -0.01% | – |
MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -7,180 | -100.0% | -0.01% | – |
AET | Exit | AETNA INC NEW | $0 | – | -4,140 | -100.0% | -0.01% | – |
MGLN | Exit | MAGELLAN HEALTH SVCS INC | $0 | – | -4,580 | -100.0% | -0.01% | – |
MD | Exit | MEDNAX INC | $0 | – | -2,750 | -100.0% | -0.01% | – |
WOOF | Exit | VCA ANTECH INC | $0 | – | -9,430 | -100.0% | -0.01% | – |
AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -5,400 | -100.0% | -0.01% | – |
HLS | Exit | HEALTHSOUTH CORP | $0 | – | -8,380 | -100.0% | -0.01% | – |
LPNT | Exit | LIFEPOINT HOSPITALS INC | $0 | – | -5,990 | -100.0% | -0.01% | – |
CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -6,830 | -100.0% | -0.01% | – |
FURX | Exit | FURIEX PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -0.02% | – |
ASTX | Exit | ASTEX PHARMACEUTICALS INC | $0 | – | -94,196 | -100.0% | -0.03% | – |
VICL | Exit | VICAL INCcall | $0 | – | -800,000 | -100.0% | -0.04% | – |
AVNR | Exit | AVANIR PHARMACEUTICALS INCput | $0 | – | -386,000 | -100.0% | -0.07% | – |
PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -338,136 | -100.0% | -0.07% | – |
AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -289,600 | -100.0% | -0.08% | – |
VNDA | Exit | VANDA PHARMACEUTICALS INCput | $0 | – | -193,000 | -100.0% | -0.09% | – |
TKMR | Exit | TEKMIRA PHARMACEUTICALS CORP | $0 | – | -318,618 | -100.0% | -0.09% | – |
MYGN | Exit | MYRIAD GENETICS INCcall | $0 | – | -116,600 | -100.0% | -0.11% | – |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEWcall | $0 | – | -96,600 | -100.0% | -0.14% | – |
KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -0.17% | – |
MDVN | Exit | MEDIVATION INC | $0 | – | -96,500 | -100.0% | -0.24% | – |
MZOR | Exit | MAZOR ROBOTICS LTDsponsored ads | $0 | – | -354,156 | -100.0% | -0.25% | – |
PSDV | Exit | PSIVIDA CORP | $0 | – | -1,544,000 | -100.0% | -0.26% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INCput | $0 | – | -579,000 | -100.0% | -0.27% | – |
ANIK | Exit | ANIKA THERAPEUTICS INC | $0 | – | -288,134 | -100.0% | -0.28% | – |
CNDO | Exit | CORONADO BIOSCIENCES INCput | $0 | – | -1,003,800 | -100.0% | -0.29% | – |
ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -1,145,740 | -100.0% | -0.29% | – |
ITMN | Exit | INTERMUNE INC | $0 | – | -600,000 | -100.0% | -0.38% | – |
RPRX | Exit | REPROS THERAPEUTICS INCcall | $0 | – | -386,000 | -100.0% | -0.43% | – |
VNDA | Exit | VANDA PHARMACEUTICALS INCcall | $0 | – | -965,200 | -100.0% | -0.44% | – |
AMRN | Exit | AMARIN CORP PLCput | $0 | – | -1,737,000 | -100.0% | -0.45% | – |
ISIS | Exit | ISIS PHARMACEUTICALS INC | $0 | – | -385,600 | -100.0% | -0.60% | – |
WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -264,162 | -100.0% | -0.76% | – |
VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -1,737,000 | -100.0% | -0.78% | – |
P103PS | Exit | NPS PHARMACEUTICALS INC | $0 | – | -611,524 | -100.0% | -0.80% | – |
SGMO | Exit | SANGAMO BIOSCIENCES INC | $0 | – | -1,930,000 | -100.0% | -0.83% | – |
AMGN | Exit | AMGEN INC | $0 | – | -183,350 | -100.0% | -0.84% | – |
IWM | Exit | ISHARESput | $0 | – | -193,000 | -100.0% | -0.85% | – |
ANAC | Exit | ANACOR PHARMACEUTICALS INC | $0 | – | -1,947,736 | -100.0% | -0.85% | – |
PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -544,068 | -100.0% | -1.08% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INCput | $0 | – | -5,116,200 | -100.0% | -1.11% | – |
SNTA | Exit | SYNTA PHARMACEUTICALS CORP | $0 | – | -4,762,472 | -100.0% | -1.24% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,221,230 | -100.0% | -1.38% | – |
QCOR | Exit | QUESTCOR PHARMACEUTICALS INC | $0 | – | -752,700 | -100.0% | -1.80% | – |
IBB | Exit | ISHARESput | $0 | – | -289,600 | -100.0% | -2.50% | – |
ONXX | Exit | ONYX PHARMACEUTICALS INC | $0 | – | -1,113,888 | -100.0% | -5.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-03-20 |
SC 13G | 2024-03-14 |
SC 13G | 2024-03-11 |
SC 13G/A | 2024-03-06 |
SC 13D/A | 2024-03-01 |
SC 13G | 2024-03-01 |
SC 13D/A | 2024-02-29 |
13F-HR/A | 2024-02-26 |
SC 13G/A | 2024-02-23 |
4 | 2024-02-21 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.